3,466
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?

ORCID Icon

References

  • Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658.
  • Tackling drug-resistant infections globally: final report and recommendations/the Review on Antimicrobial Resistance chaired by Jim O’Neill. 2016. Available from: https://wellcomecollection.org/works/thvwsuba
  • Kwon JH, Powderly WG. The post-antibiotic era is here. Science. 2021;373:471.
  • Lai -C-C, Chen S-Y, Ko W-C, et al. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57:106324.
  • Founou RC, Blocker AJ, Noubom M, et al. The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA. 2021;7:FSO736.
  • Ghosh C, Sarkar P, Issa R, et al. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 2019;27:323–338.
  • Micoli F, Bagnoli F, Rappuoli R, et al. The role of vaccines in combatting antimicrobial resistance. Nature Rev Microbiol. 2021;19:287–302.
  • Morel CM, Lindahl O, Harbarth S, et al. Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus. J Antibiot (Tokyo). 2020;73:421–428.
  • Li Y, Tenchov R, Smoot J, et al. A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Cent Sci. 2021;7:512–533.
  • Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. Lancet Microbe. 2021;2:e279–e280.
  • Nasreen S, Chung H, He S, et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. medRxiv. 2021:2021.2006.2028.21259420.
  • Fan X-Y, Lowrie DB. Where are the RNA vaccines for TB? Emerg Microbes Infect. 2021;10:1217–1218.
  • Wu K, Choi A, Koch M, et al. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. bioRxiv. 2021:2021.2004.2013.439482.
  • Mallory KL, Taylor JA, Zou X, et al. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice. Npj Vaccines. 2021;6:84.
  • Xue T, Stavropoulos E, Yang M, et al. RNA encoding the MPT83 antigen induces protective immune responses against mycobacterium tuberculosis infection. Infect Immun. 2004;72:6324–6329.
  • Maruggi G, Chiarot E, Giovani C, et al. Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens. Vaccine. 2017;35:361–368.
  • Dolgin E. CureVac COVID vaccine let-down spotlights mRNA design challenges. Nature. 2021;594:483.
  • Fuller DH, Phimister EG, Berglund P. Amplifying RNA vaccine development. N Engl J Med. 2020;382:2469–2471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.